Pharmstandard Investor
Pharmstandard develops and manufactures pharmaceutical products designed to meet the requirements of the healthcare system and the needs of patients. Pharmstandard manufactures medicines for a range of conditions, including cardiovascular diseases, diabetes mellitus, growth hormone deficiency, gastroenterological and infectious diseases, neurological disorders, metabolic disorders, oncology, and other illnesses.
Headquarters:
Moscow,Moscow City,Russian Federation,Europe
Employee Number:
5001-10000
Industry:
Advanced BioTech R&D
Number Of Exists:
6
Investor Type:
Private Equity Funds
Founded Date:
2003-01-01
Funding Status:
delisted
